ZCZhee Yee Chan

Zhee Yee Chan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhee Yee Chan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Potential Role of Amyloid Precursor Protein Fragments as a Screening Tool for Mild Cognitive Impairment

    by Hui Xin Oh, Shin Rou Khor, Juen Kiem Tan, Michelle Maryanne Tan, Ching Soong Khoo, Zi Qi Ang, Zhee Yee Chan, Nor Syazwani Chamhuri, Hazlina Mahadzir, Kong Heng Lee, et al.

    Background: Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia, in which early detection is essential. Urinary amyloid precursor protein (APP) fragments have been proposed as a non‐invasive biomarker, but their diagnostic value in elderly populations remains uncertain. This study evaluated the diagnostic performance of urinary APP fragments, particularly amyloid‐β protein precursor (AβPP), for MCI screening and examined associated sociodemographic and clinical risk factors among adults aged ≥ 65 years. Methods: A single‐center, cross‐sectional, case–control study was conducted at Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia. A total of 140 age‐ and gender‐matched participants were recruited (70 MCI, 70 cognitively normal). Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA). Urinary AβPP was measured using a lateral flow immunochromatography kit. Data on comorbidities, body mass index, education level and smoking status were collected. Diagnostic accuracy and logistic regression analyses were performed. Results: The urinary AβPP test showed a sensitivity of 74.3%, specificity of 27.1%, and overall accuracy of 50.7%, with no significant association with cognitive status ( p = 0.424). Diabetes mellitus was an independent risk factor predictor for MCI ( p = 0.007, OR = 5.764, 95% CI 1.615–20.572) along with age ( p = 0.001, OR = 1.638, 95% CI 1.234–2.175). Conclusion: Urinary AβPP shows high sensitivity but low specificity for MCI screening. Diabetes mellitus is a significant predictor of MCI, highlighting the role of metabolic health in early cognitive decline.

  • Response to Letter to the Editor titled “Beyond passive listening: Optimizing music‐based interventions in pediatric epilepsy”

    by Kah Hui Yap, Marjorie Jia Yi Ong, Juen Kiem Tan, Cyena Chaza Anak Kutiang, Zi Qi Ang, Zhee Yee Chan, Siew Tim Lai, Ching Soong Khoo, Hui Jan Tan

  • Music‐based intervention as an adjunctive therapy in people with epilepsy: A scoping review

    by Kah Hui Yap, Marjorie Jia Yi Ong, Juen Kiem Tan, Cyena Chaza Anak Kutiang, Zi Qi Ang, Zhee Yee Chan, Siew Tim Lai, Ching Soong Khoo, Hui Jan Tan

    Epilepsy is a major neurological disorder that affects individuals across all age groups and can significantly impair their quality of life. Although pharmacological treatments are available, there remains a need for complementary non‐pharmacological lifestyle interventions. Music‐based intervention (MBI) is a possible option, as it is non‐invasive, cost‐effective, and easily implemented. This scoping review aims to identify and describe MBIs used in the management of epilepsy. A systematic search was conducted from April 9 to June 10, 2025, using two electronic databases: Ovid Medline and Scopus. The protocol was prospectively registered with the Research Ethics Committee of Universiti Kebangsaan Malaysia (FF‐2025‐173) and PROSPERO (CRD420251119617). Of the 3977 articles identified, 21 studies investigating MBIs for epilepsy met the inclusion criteria. Ten studies were rated as having a high risk of bias based on the Cochrane risk‐of‐bias assessment tool. The remaining studies provided Class II evidence according to both the GRADE and OCEBM frameworks. Most studies used passive listening of pre‐recorded Mozart K.448 for intervention. Overall, MBIs were assigned a Level C recommendation for epilepsy. MBIs for epilepsy require further investigations with robust study designs and a standardized protocol. Heterogeneous study designs and small samples are likely barriers to meaningful clinical translation. Therefore, the rating of recommendations only serves as a point of reference. Future avenues include live performance and reminiscence elements.